Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-59.81	28.11	69.94
Graham Fair Price	76.93	2.30	1.30
PEG	-92.46	0.04	-0.59
Price/Book	-19.40	0.80	0.99
Price/Cash Flow	-26.37	8.17	-11.10
Prices/Earnings	-73.97	9.39	36.06
Price/Sales	-1.46	2.36	2.40
Price/FCF	-26.37	8.17	-11.10
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	44.54	0.17	0.12
Operating Margin	110.61	0.11	0.05
ROA	221.15	< 0.005	< 0.005
ROE	< 0.005	0.02	209.62
ROIC	< 0.005	0.02	110.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.10	0.10	4.34
Dividends QOQ	0.24	-0.16	-35.71
EBIT QOQ	-0.21	0.73	256.08
EPS QOQ	-0.61	2.11	245.19
FCF QOQ	-1.88	2.10	11.86
Revenue QOQ	-0.15	-0.18	-18.14
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	41.65	52.97	27.20
Days Sales Outstanding (DSO)	38.21	63.59	66.39
Inventory Turnover	2.16	1.70	-21.38
Debt/Capitalization	0.46	0.43	-6.25
Quick Ratio	0.42	0.59	42.55
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	3.30	3.75	13.59
Cash	0.73	0.85	16.05
Capex	-0.02	0.04	73.49
Free Cash Flow	-0.29	0.32	10.07
Revenue	1.36	1.12	-17.76
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.67	0.76	13.85
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	27.86	11.17	-59.89
Naive Interpretation	Member

06 - Financial Health · Bad

Rating